feed,title,long_url,short_url
SSRN,Avoiding the TRIPS Trap: A Path to Domestic Disclosure of Clinical Drug Data Consistent with International Norms,https://ssrn.com/abstract=3667995,
SSRN,Flatten the Bureaucracy: Deregulation and Covid-19 Testing,https://ssrn.com/abstract=3668493,
SSRN,Policies and Innovations to Battle COVID-19 – A Case Study of South Korea,https://ssrn.com/abstract=3666758,
SSRN,Does Service Provider Matter During a Pandemic? COVID-19 Cases and Deaths Among Nonprofit vs. For-Profit Assisted Living Facilities in Florida,https://ssrn.com/abstract=3651404,
SSRN,"Employee Testing, Tracing, and Disclosure as a Response to the Coronavirus Pandemic",https://ssrn.com/abstract=3667212,
SSRN,Restriction of Fundamental Rights in a Context of Emergency: COVID-19 and the Aspect of Autonomy – Can Autonomy Be Limited?,https://ssrn.com/abstract=3667367,
SSRN,Pandemic Lockdowns: A Political Science Perspective,https://ssrn.com/abstract=3667210,
SSRN,Retos del COVID-19 para el derecho y la política de competencia en América Latina y el Caribe (COVID-19 Challenges for Competition Law and Policy in Latin America and the Caribbean),https://ssrn.com/abstract=3663905,
SSRN,"Gold, the Golden Constant, COVID-19, 'Massive Passives' and Déjà Vu",https://ssrn.com/abstract=3667789,
